In the past 12‑18 months, the Anhydrous HOBt market has seen a wave of strategic activity that reshapes supply dynamics and innovation pipelines. In March 2023, SigmaChem entered a global distribution partnership with BASF Advanced Materials, expanding access to high‑purity Anhydrous HOBt across Europe and Asia. July 2023 marked the acquisition of J&K Reagents by Thermo Fisher Scientific, consolidating a leading position in peptide‑synthesis reagents. Early 2024, Merck KGaA launched HOBt‑Pure‑X, a moisture‑controlled formulation that claims >99.9 % purity and reduced safety hazards, prompting rapid adoption in contract manufacturing organisations. On the regulatory front, the European Chemicals Agency (ECHA) revised its classification of HOBt derivatives in February 2024, easing transport restrictions while tightening reporting thresholds for occupational exposure. Meanwhile, a shift toward continuous flow peptide synthesis is driving demand for more stable anhydrous grades, a trend echoed in recent conference panels. Finally, ChemBridge secured a $45 million Series B round to scale its automated packaging line, slated for commissioning Q4 2024. These Anhydrous HOBt industry trends signal accelerated consolidation, heightened safety focus, and a clear move toward greener, high‑efficiency manufacturing.
